Market Closed -
Bombay S.E.
03:30:59 21/06/2024 pm IST
|
5-day change
|
1st Jan Change
|
44.5
INR
|
-2.52%
|
|
-4.87%
|
-56.28%
|
Fiscal Period: März |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
99.42
|
82.17
|
42.03
|
68.31
|
113.2
|
260.2
|
Enterprise Value (EV)
1 |
83.88
|
60.66
|
4.558
|
22.31
|
69.64
|
215.2
|
P/E ratio
|
878
x
|
26.4
x
|
-9.54
x
|
-28.4
x
|
-69.2
x
|
8.19
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
2.11
x
|
0.88
x
|
2.69
x
|
7,425
x
|
-
|
5.96
x
|
EV / Revenue
|
1.78
x
|
0.65
x
|
0.29
x
|
2,426
x
|
-
|
4.93
x
|
EV / EBITDA
|
-13.5
x
|
-7.44
x
|
-0.66
x
|
-4.24
x
|
-18.2
x
|
7.42
x
|
EV / FCF
|
1.05
x
|
-8.53
x
|
0.31
x
|
2.93
x
|
-19
x
|
-17.4
x
|
FCF Yield
|
95.3%
|
-11.7%
|
318%
|
34.1%
|
-5.26%
|
-5.76%
|
Price to Book
|
1.74
x
|
1.36
x
|
0.75
x
|
1.27
x
|
2.18
x
|
3.11
x
|
Nbr of stocks (in thousands)
|
6,273
|
6,273
|
6,273
|
6,273
|
6,273
|
6,273
|
Reference price
2 |
15.85
|
13.10
|
6.700
|
10.89
|
18.05
|
41.48
|
Announcement Date
|
31/08/18
|
29/08/19
|
06/09/20
|
03/09/21
|
30/08/22
|
08/09/23
|
Fiscal Period: März |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
47.02
|
92.86
|
15.6
|
0.0092
|
-
|
43.66
|
EBITDA
1 |
-6.224
|
-8.153
|
-6.859
|
-5.269
|
-3.833
|
29.02
|
EBIT
1 |
-6.751
|
-8.166
|
-6.875
|
-5.295
|
-3.881
|
28.98
|
Operating Margin
|
-14.36%
|
-8.79%
|
-44.06%
|
-57,551.77%
|
-
|
66.39%
|
Earnings before Tax (EBT)
1 |
0.4882
|
3.082
|
-4.405
|
-2.406
|
-1.635
|
31.76
|
Net income
1 |
0.1132
|
3.117
|
-4.405
|
-2.406
|
-1.635
|
31.76
|
Net margin
|
0.24%
|
3.36%
|
-28.23%
|
-26,153.07%
|
-
|
72.74%
|
EPS
2 |
0.0181
|
0.4969
|
-0.7023
|
-0.3836
|
-0.2607
|
5.062
|
Free Cash Flow
1 |
79.9
|
-7.115
|
14.49
|
7.616
|
-3.66
|
-12.4
|
FCF margin
|
169.94%
|
-7.66%
|
92.87%
|
82,785.28%
|
-
|
-28.41%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
70,562.58%
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
31/08/18
|
29/08/19
|
06/09/20
|
03/09/21
|
30/08/22
|
08/09/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
15.5
|
21.5
|
37.5
|
46
|
43.6
|
45
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
79.9
|
-7.11
|
14.5
|
7.62
|
-3.66
|
-12.4
|
ROE (net income / shareholders' equity)
|
0.2%
|
5.3%
|
-7.58%
|
-4.39%
|
-3.1%
|
46.8%
|
ROA (Net income/ Total Assets)
|
-3.83%
|
-7.79%
|
-6.61%
|
-5.71%
|
-4.51%
|
25.6%
|
Assets
1 |
-2.957
|
-40.01
|
66.65
|
42.17
|
36.29
|
124.2
|
Book Value Per Share
2 |
9.120
|
9.630
|
8.910
|
8.540
|
8.290
|
13.40
|
Cash Flow per Share
2 |
0.8300
|
0.4300
|
0.3800
|
0.3900
|
0.0800
|
0.1800
|
Capex
1 |
0.07
|
0.01
|
-
|
-
|
-
|
-
|
Capex / Sales
|
0.16%
|
0.01%
|
-
|
-
|
-
|
-
|
Announcement Date
|
31/08/18
|
29/08/19
|
06/09/20
|
03/09/21
|
30/08/22
|
08/09/23
|
|
1st Jan change
|
Capi.
|
---|
| -56.28% | 3.34M | | +1.73% | 100B | | -10.42% | 58.78B | | +64.29% | 45.36B | | +8.44% | 36.02B | | +0.14% | 31B | | +5.72% | 19.02B | | +10.56% | 16.45B | | +4.56% | 13.35B | | -5.80% | 12.85B |
Other Commodity Chemicals
|